Skip to main content
Molecular Medicine logoLink to Molecular Medicine
. 1995 Sep;1(6):659–666.

Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.

M Gapany 1, R A Faust 1, S Tawfic 1, A Davis 1, G L Adams 1, K Ahmed 1
PMCID: PMC2229971  PMID: 8529132

Abstract

BACKGROUND: Protein kinase CK2 (also known as casein kinase 2) is a messenger-independent protein serine/threonine kinase ubiquitously distributed in eukaryotes. CK2 has been found to phosphorylate a wide variety of cytosolic and nuclear substrates which are intimately involved in regulation of DNA, RNA, and protein synthesis, and differentiation. We therefore addressed the hypothesis that malignant transformation of upper aerodigestive tract mucosa to squamous cell carcinoma of the head and neck (SCCHN) might be associated with altered CK2 activity. MATERIALS AND METHODS: To this end, we subjected surgical specimens of SCCHN tumors and of normal oropharyngeal mucosa to subcellular fractionation. We then quantitated CK2 activity in cytosol and nuclei of these specimens using a CK2-specific peptide substrate (Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu). RESULTS: We found that CK2 activity was significantly elevated in both nuclear (p < 0.0005) and cytosolic (p < 0.0034) compartments of SCCHN tumors, relative to normal oropharyngeal mucosa. Moreover, CK2 activity in the cellular cytosolic fraction of SCCHN tumors was associated with less differentiated histologic grade (p < 0.037), positive nodal metastatic status (p < 0.056), and a poor clinical outcome (p < 0.028). Kaplan-Meier cumulative survival analysis revealed greatly reduced survival in the high-CK2 activity patient group, with high statistical significance (p < 0.023). CONCLUSIONS: These preliminary data reveal that malignant transformation of the upper aerodigestive tract mucosa is associated with altered CK2 activity. The results further suggest that dysregulation of this protein kinase may play a significant role in the pathobiology of SCCHN, and that CK2 activity may be a prognostic indicator in this malignancy.

Full text

PDF
659

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A. Growth factors and cancer. Science. 1991 Nov 22;254(5035):1146–1153. doi: 10.1126/science.1659742. [DOI] [PubMed] [Google Scholar]
  2. Ahmed K. Significance of the casein kinase system in cell growth and proliferation with emphasis on studies of the androgenic regulation of the prostate. Cell Mol Biol Res. 1994;40(1):1–11. [PubMed] [Google Scholar]
  3. Ahmed K., Yenice S., Davis A., Goueli S. A. Association of casein kinase 2 with nuclear chromatin in relation to androgenic regulation of rat prostate. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4426–4430. doi: 10.1073/pnas.90.10.4426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantley L. C., Auger K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 1991 Jan 25;64(2):281–302. doi: 10.1016/0092-8674(91)90639-g. [DOI] [PubMed] [Google Scholar]
  5. Coltrera M. D., Zarbo R. J., Sakr W. A., Gown A. M. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol. 1992 Oct;141(4):817–825. [PMC free article] [PubMed] [Google Scholar]
  6. Crissman J. D., Zarbo R. J. Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract. Am J Surg Pathol. 1989;13 (Suppl 1):5–16. [PubMed] [Google Scholar]
  7. Devesa S. S., Silverman D. T., Young J. L., Jr, Pollack E. S., Brown C. C., Horm J. W., Percy C. L., Myers M. H., McKay F. W., Fraumeni J. F., Jr Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987 Oct;79(4):701–770. [PubMed] [Google Scholar]
  8. Hunter T., Karin M. The regulation of transcription by phosphorylation. Cell. 1992 Aug 7;70(3):375–387. doi: 10.1016/0092-8674(92)90162-6. [DOI] [PubMed] [Google Scholar]
  9. Issinger O. G. Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol Ther. 1993;59(1):1–30. doi: 10.1016/0163-7258(93)90039-g. [DOI] [PubMed] [Google Scholar]
  10. Lorenz P., Pepperkok R., Ansorge W., Pyerin W. Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling. J Biol Chem. 1993 Feb 5;268(4):2733–2739. [PubMed] [Google Scholar]
  11. Münstermann U., Fritz G., Seitz G., Lu Y. P., Schneider H. R., Issinger O. G. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem. 1990 Apr 30;189(2):251–257. doi: 10.1111/j.1432-1033.1990.tb15484.x. [DOI] [PubMed] [Google Scholar]
  12. Pelech S. L., Sanghera J. S., Daya-Makin M. Protein kinase cascades in meiotic and mitotic cell cycle control. Biochem Cell Biol. 1990 Dec;68(12):1297–1330. doi: 10.1139/o90-194. [DOI] [PubMed] [Google Scholar]
  13. Santini J., Formento J. L., Francoual M., Milano G., Schneider M., Dassonville O., Demard F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 1991 Mar-Apr;13(2):132–139. doi: 10.1002/hed.2880130209. [DOI] [PubMed] [Google Scholar]
  14. Scambia G., Panici P. B., Battaglia F., Ferrandina G., Almadori G., Paludetti G., Maurizi M., Mancuso S. Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer. 1991 Mar 1;67(5):1347–1351. doi: 10.1002/1097-0142(19910301)67:5<1347::aid-cncr2820670513>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  15. Seldin D. C., Leder P. Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle. Science. 1995 Feb 10;267(5199):894–897. doi: 10.1126/science.7846532. [DOI] [PubMed] [Google Scholar]
  16. Shin D. M., Ro J. Y., Hong W. K., Hittelman W. N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994 Jun 15;54(12):3153–3159. [PubMed] [Google Scholar]
  17. Shin D. M., Voravud N., Ro J. Y., Lee J. S., Hong W. K., Hittelman W. N. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Inst. 1993 Jun 16;85(12):971–978. doi: 10.1093/jnci/85.12.971. [DOI] [PubMed] [Google Scholar]
  18. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  19. Snow G. B., Annyas A. A., van Slooten E. A., Bartelink H., Hart A. A. Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci. 1982 Jun;7(3):185–192. doi: 10.1111/j.1365-2273.1982.tb01581.x. [DOI] [PubMed] [Google Scholar]
  20. Sommercorn J., Mulligan J. A., Lozeman F. J., Krebs E. G. Activation of casein kinase II in response to insulin and to epidermal growth factor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8834–8838. doi: 10.1073/pnas.84.24.8834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tawfic S., Ahmed K. Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. Evidence based on androgen action in the prostate. J Biol Chem. 1994 Oct 7;269(40):24615–24620. [PubMed] [Google Scholar]
  22. Walther E. K., Dahlmann N., Gorgulla H. T. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase. Head Neck. 1993 May-Jun;15(3):230–235. doi: 10.1002/hed.2880150310. [DOI] [PubMed] [Google Scholar]
  23. Wolf G. T., Carey T. E., Schmaltz S. P., McClatchey K. D., Poore J., Glaser L., Hayashida D. J., Hsu S. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 1990 Oct 3;82(19):1566–1572. doi: 10.1093/jnci/82.19.1566. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ

RESOURCES